InhibitENZ

InhibitENZ

A novel drug for the treatment of the chronic eye disease, cataract.

Objective

Seeking Licensees

Unique Selling Propositions
  • Technology is aimed at newly diagnosed cataract patients and has the aim of enabling immediate treatment. In addition to cataract, Calpain may also be effective against a number of other common eye diseases, such as glaucoma and AMD, via prevention or reduction of retina and optic nerve head damage
Applications
  • Treatment of eye disease
IP Strategy

US patent has entered National Phase

Project Status

Product ready for early adoption